AAP Implantate AG closed a distribution contract with a U.S. healthcare service provider for its LOQTEQ products.

The contract initially provides for a 12-month pilot phase in which the contractual partner will sell LOQTEQ products in a number of selected U.S. states. If it proves to be successful, distribution will gradually be rolled out to further states.